Abstract
Esophageal cancer is a highly lethal disease. Despite an increasing incidence of adenocarcinoma in last decades, squamous cell carcinoma remains the predominant cell type worldwide. The majority of squamous cell cancers are from the East. Risk factors for the development of esophageal squamous cell carcinoma differ between high- and low-incidence regions. Tobacco and alcohol intake are the two major risks factors for esophageal squamous cell carcinoma. They also have a synergistic effect; the mechanism of which is now better understood. Other dietary factors include lack of certain micronutrients, consumption of food with carcinogenic ingredients, eating habits and food preservation methods. Genetic factors, viral infection and other premalignant conditions also play a role. Studying epidemiology and pathogenesis of the disease allows policymakers to enact public health policies to prevent the disease through health education and risk factors avoidance. Screening for early disease detection in high-risk populations could improve overall outcome.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
Introduction
Esophageal cancer is a disease of dismal prognosis. The two major histologic types of tumors, squamous cell carcinoma and adenocarcinoma, differ substantially in epidemiology, and pathogenesis. Squamous cell carcinoma remains the main cell type worldwide and most are found in Eastern populations. The cancer is characterized by late presentation and rapidly fatal course. This makes study on modifiable risk factors for esophageal cancer particularly important in the context of disease prevention. The present chapter addresses the epidemiology and pathogenesis with emphasis on esophageal squamous cell carcinoma (ESCC).
Epidemiology
Esophageal cancer is the 8th most common cancer globally and the 6th most common cause of cancer-related deaths [1]. Despite advances in diagnostic methods and multimodal therapy in high-income countries, survival rate at 5 years from esophageal cancer remains low. The reported five-year survival rates for esophageal cancer are 21% in China [2], 20% in the United States [3], 9.8% in Europe [4], and < 5% in places where resources are limited [5, 6]. There were an estimated 512,500 new cases of ESCC in 2020, representing 85% of all esophageal cancers [7, 8]. Although there has been a decline in the incidence of ESCC in certain parts of the world, probably related to improvement in living standard and lifestyle habits, ESCC remains the predominant histologic type worldwide.
ESCC is a male-predominant disease and is the most common histological type for both men and women. There is significant variation of incidence among different geographic regions and various ethnic groups. The incidence rates of ESCC are highest in Eastern and South-Central Asia and South Africa. In Asian countries, it is commonly found in the “Asian esophageal cancer belt”, bounded by eastern Turkey and east of Caspian Sea through northern Iran, northern Afghanistan, and southern areas of the former Soviet Union, such as Turkmenistan, Uzbekistan, and Tajikistan, to northern China and India. In high-incidence areas worldwide, including Linxian province in China, Golestan province in Iran, Western Kenya south to Malawi, the Eastern Cape province of South Africa, Calvados in France, Southern Brazil and Uruguay, the occurrence of esophageal cancer is 50–100-fold higher than that in the rest of the world.
In China, ESCC is the 4th most frequently diagnosed cancer and the 4th leading cause of cancer deaths. The age-standardized incidence rate of ESCC in China is 12.5 per 100,000 person-years, compared to 5.6 in the rest of the Eastern Asia, 1.8 in Northern Europe, 2.3 in Western Europe, 0.9 in North America, and 1.2 in Australia/New Zealand. The crude age-adjusted mortality is up to 12.7 per 100,000 person-years [1]. Incidence is generally higher in rural areas, of which provinces like Henan, Hebei and Shanxi have the highest incidence rates in the world. Esophageal cancer most commonly presents in the sixth and seventh decades of life and is rare before the fourth decade. About 70% of the patients in Japan are in their 60 s and 70 s at the time of diagnosis according to the Population-Based Cancer Registry. Similarly, the incidence of ESCC peaks at 70–80 years of age according to National Central Cancer Registry of China [9, 10].
Pathogenesis
Several etiological factors are in association with ESCC, of which, consumption of tobacco, alcohol, hot beverages and nitrosamines, genetic factors, and personal history of squamous cell carcinoma in the head and neck region and the esophagus are most studied (Table 1).
Alcohol and Smoking
Tobacco and alcohol consumption are the two major risks factors for ESCC. Smoking is regarded by the International Agency for Research on Cancer (IARC) as a cause of esophageal cancer [11]. Compared to non-alcohol drinkers, the risk of ESCC increases by 38%, 260% and 550% among those who drink alcohol 1–1.5 L/day, 1.5–6 L/day and > 6L/day, respectively [12, 13]. Alcohol and smoking have synergistic effect on the risk of ESCC. The mechanism is well studied. Alcohol damages cellular DNA by decreasing metabolic activity within cells, thereby reduces detoxification function and promotes oxidation [14]. It acts as a solvent for fat-soluble carcinogens such as aromatic amines, nitrosamines, polycyclic aromatic hydrocarbons, phenols, and aldehyde. Therefore, these substances from tobacco can easily diffuse to the esophageal tissue. A meta-analysis showed that the combined effect of drinking and smoking doubled the sum of their effects individually [15]. In low- or medium-incidence populations like in Europe and the United States, ESCC is largely attributed to smoking and alcohol [16, 17]. In the United States, United Kingdom, and France, population attributable risks of 57–73% have been reported for squamous cell carcinoma, based on reduction of smoking and alcohol use, and consumption of fruits and vegetables [17,18,19,20]. Similarly, studies in high incidence countries in Asia such as China estimated that 48.5% of esophageal cancers were attributable to the combined effect of alcohol, smoking and low fruit and vegetable intake [21].
Genetic Factors
Genetic predisposition may be related to the pathogenesis of ESCC. Genome-wide association studies have demonstrated a high heritability of ESCC when compared to other cancers [22], and there is an increased risk of ESCC in people who have a positive family history [23,24,25]. Mitochondrial studies have proved historical population migrations from central / northern to southern-eastern China; the two regions share the same high risk of ESCC and yet environmentally they are quite different [26].
Tylosis, characterized by hyperkeratosis of palms and soles, is a familial esophageal cancer syndrome inherited as an autosomal dominant trait. It has been reported to be associated with genetic mutations in RHBDF2 [27].
Genetic polymorphism is important in individuals with chronic alcohol consumption. Polymorphisms in alcohol dehydrogenase 1B (ADH1B), alcohol dehydrogenase (ADH7), and aldehyde dehydrogenase 2 (ALDH2) are known to alter ethanol metabolism. Approximately 36% of East Asians show a physiologic response to drinking that includes facial flushing, nausea, and tachycardia [28]. This facial flushing response is predominantly related to an inherited deficiency in the enzyme ALDH2. Alcohol is metabolized to acetaldehyde by alcohol dehydrogenase and the acetaldehyde is in turn metabolized by ALDH2 to acetate. Two main variants for ALDH2 exist, resulting from the replacement of glutamate with lysine at position 487. Only individuals homozygous with the glutamate allele have normal catalytic activity. Homozygotes with the lysine alleles have no detectable activity, while heterozygotes with Glu/Lys alleles have much reduced ALDH2 activity. The inability to fully metabolize acetaldehyde results in its accumulation in the body leading to the facial flushing and unpleasant side effects. Lys/Lys homozygotes cannot tolerate much alcohol because of the intensity of the side effects, and so paradoxically they do not have increased risk because they simply would not consume a significant amount of alcohol. Individuals who are Glu/Lys heterozygotes may become habitual drinkers because they could become tolerant to the side effects of alcohol and yet they had suboptimal catalytic activity and thus the acetaldehyde accumulates. These are the individuals most susceptible to the carcinogenic effects of alcohol consumption, which is related to acetaldehyde causing DNA damage and other cancer-promoting effects [29]. A simple questionnaire that elicits the history of a flushing response can be useful in identifying at-risk individuals, who could be advised against drinking or to undergo screening endoscopy. The risk of developing cancer may be reduced, or an earlier diagnosis could be possible [30].
Diet and Environment
In Asian countries, dietary and environmental factors certainly play a role in the development of ESCC. Studies have investigated the effects of dietary patterns, specific food and nutrients on the disease [31, 32]. Nitrosamines and their precursors such as nitrate, nitrite, and secondary amines, are found in pickled vegetables, which in turn have been shown to increase risk [33]. Nutritional depletion of certain micronutrients, particularly vitamins A, C, E, niacin, riboflavin, molybdenum, manganese, zinc, magnesium selenium, as well as fresh fruits and vegetables, together with an inadequate protein intake, predisposes the esophageal epithelium to neoplastic transformation [34]. While the lack of fresh fruit and vegetables is associated with increased risk of ESCC [35], meta-analyses showed that eating fruits and vegetables significantly reduced ESCC risk [36, 37]. The Nutrition Intervention Trial conducted in Linxian county in China showed that consumption of vitamin B2 and nicotinic acid decreased the incidence of esophageal cancer by 14%, while beta-carotene, vitamin E, and selenium intake could reduce esophageal cancer mortality by 17% in patients less than 55 years old [38].
Consumption of red meat, processed meat, and hot mate were shown to be associated with increased risk of ESCC [39, 40]. A meta-analysis showed that the cancer risk was 57% higher in people who consumed a large amount of red meat and 55% higher in people who took a large amount of processed meat [40]. Mate drinkers have a 60–260% increased ESCC risk compared to non-drinkers in South American countries [41, 42].
Change in specific dietary habits, such as replacing traditional methods of food preservation and storage with refrigeration, together with consumption of vitamin-rich food, may have produced a reduction in incidence rates in certain areas of China, especially in urban cities such as Shanghai [43, 44]. Consumption of hot food and beverages is associated with an increased risk of esophageal cancer, particularly squamous cell cancer [45, 46].
Infection
Infective pathogens including human papillomavirus (HPV), Fusarium, Alternaria, Geotrichum, Aspergillus, Cladosporium, and Penicillium species are found to be associated with esophageal cancer in some studies. The role of HPV, debated in more recent studies, is now controversial. Therefore, HPV vaccines may not be beneficial in ESCC prevention [47,48,49,50,51].
Premalignant/Neoplastic Condition
Patients with other aerodigestive malignancies have a particularly high risk of developing ESCC, presumably because of exposure to similar environmental carcinogens and “field cancerization”. This concept was introduced by Slaughter and colleagues. It was postulated that clonal expansion develops in mucosa adjacent to an initial area of genetic and epigenetic alternations. This results in a proliferating field of early genetic changes that is at risk of future cancer development [52,53,54]. Using esophageal cancer as the index tumor, multiple primary cancers were found in 9.5% of patients, of whom 70% were in the aerodigestive tract [55]. The overall incidence of synchronous or metachronous esophageal cancer in patients with primary head and neck cancer is estimated to be 3–6% [56, 57].
Diseases that are known to predispose to esophageal cancer are few. The risk from achalasia is estimated to be 7- to 33-fold, but symptoms of achalasia are present for an average of 15–20 years before the emergence of cancer [58]. Other diseases include lye corrosive strictures, Plummer-Vinson syndrome, tylosis, and celiac disease.
Other Factors
Low socioeconomic status is associated with increased risk of ESCC. It is believed to be an interplay of many factors including poorer nutritional status, lacking of fresh food and produce, poor oral hygiene and tooth loss. Studies showed that tooth brushing exerts protective effects against ESCC and that tooth loss is associated with increased risk of ESCC [59,60,61]. These findings, however, should be interpreted carefully as poor oral hygiene may also be confounded by other lifestyle habits like smoking and drinking.
Prevention
ESCC is notorious for its poor prognosis. Being asymptomatic at an early stage, the majority of patients are diagnosed at an advanced stage. The disease tends to spread early compared to other gastrointestinal tract cancers at an equivalent depth of invasion. Identifying modifiable risk factors allows potential prevention and screening at high-incidence regions. This will facilitate early diagnosis and improve prognosis.
ESCC as aforementioned has been demonstrated to be linked with several environmental risk factors. To reduce the risk of ESCC, it is advisable to abstain from smoking and excessive alcohol drinking, consume more fresh vegetables and fruits, and minimize exposure to food carcinogens like nitrites or nitrosamine.
Early detection potentially improves survival outcome. Screening strategies and prediction models have been developed and reported [62]. Currently there is no international consensus on ESCC screening, probably because of the substantial geographic variations in prevalence and concerns on cost-effectiveness. Chromoendoscopic examination using Lugol’s iodine solution has been shown to be effective in Korea, Japan and China for screening of esophageal cancer. Magnifying endoscopy with narrow-band imaging (NBI) enables detection of superficial, early-stage cancers with high sensitivity but requires specialized training [63, 64]. These screening strategies and techniques are less applicable in low incidence regions.
Conclusion
ESCC is a fatal disease and a significant burden to the healthcare system especially in regions of high prevalence. Public health education, nutritional intervention and risk-stratified screening potentially reduce incidence rate and cancer-related deaths in high-incidence areas. Understanding of the epidemiology and pathogenesis of ESCC is essential for policymakers and stakeholders of healthcare systems to implement appropriate measures to improve the outlook of this lethal disease.
References
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of Incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.
Cao W, Chen H-D, Yu Y-W, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J. 2021;134(7).
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30. https://doi.org/10.3322/caac.21332.
Gavin AT, Francisci S, Foschi R, et al. Oesophageal cancer survival in Europe: a EUROCARE-4 study. Cancer Epidemiol. 2012;36(6):505–12. https://doi.org/10.1016/j.canep.2012.07.009.
White RE, Parker RK, Fitzwater JW, et al. Stents as sole therapy for oesophageal cancer: a prospective analysis of outcomes after placement. Lancet Oncol. 2009;10(3):240–6. https://doi.org/10.1016/s1470-2045(09)70004-x.
Dawsey SP, Tonui S, Parker RK, et al. Esophageal cancer in young people: a case series of 109 cases and review of the literature. PLoS ONE. 2010;5(11):e14080. https://doi.org/10.1371/journal.pone.0014080.
Morgan E, Soerjomataram I, Rumgay H, et al. The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: new estimates from GLOBOCAN 2020. Gastroenterology. 2022;163(3):649-58.e2. https://doi.org/10.1053/j.gastro.2022.05.054.
Uhlenhopp DJ, Then EO, Sunkara T, et al. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol. 2020;13(6):1010–21. https://doi.org/10.1007/s12328-020-01237-x.
Japan ES. Japanese classification of esophageal cancer, 11th edition: part I. Esophagus. 2017;14(1):1–36. https://doi.org/10.1007/s10388-016-0551-7.
Wang Y, Yan Q, Fan C, et al. Overview and countermeasures of cancer burden in China. Sci China Life Sci. 2023:1–12. https://doi.org/10.1007/s11427-022-2240-6.
Cogliano VJ, Baan R, Straif K, et al. Preventable exposures associated with human cancers. JNCI: J National Cancer Inst. 2011;103(24):1827–39. https://doi.org/10.1093/jnci/djr483.
Islami F, Fedirko V, Tramacere I, et al. Alcohol drinking and esophageal squamous cell carcinoma with focus on light-drinkers and never-smokers: a systematic review and meta-analysis. Int J Cancer. 2011;129(10):2473–84. https://doi.org/10.1002/ijc.25885.
Bagnardi V, Rota M, Botteri E, et al. Light alcohol drinking and cancer: a meta-analysis. Ann Oncol. 2013;24(2):301–8. https://doi.org/10.1093/annonc/mds337.
Muwonge R, Ramadas K, Sankila R, et al. Role of tobacco smoking, chewing and alcohol drinking in the risk of oral cancer in Trivandrum, India: a nested case-control design using incident cancer cases. Oral Oncol. 2008;44(5):446–54. https://doi.org/10.1016/j.oraloncology.2007.06.002.
Prabhu A, Obi KO, Rubenstein JH. The synergistic effects of alcohol and tobacco consumption on the risk of esophageal squamous cell carcinoma: a meta-analysis. Am J Gastroenterol. 2014;109(6):822–7. https://doi.org/10.1038/ajg.2014.71.
Tuyns AJ. Oesophageal cancer in non-smoking drinkers and in non-drinking smokers. Int J Cancer. 1983;32(4):443–4. https://doi.org/10.1002/ijc.2910320408.
Wang SM, Katki HA, Graubard BI, et al. Population attributable risks of subtypes of esophageal and gastric cancers in the United States. Am J Gastroenterol. 2021;116(9):1844–52. https://doi.org/10.14309/ajg.0000000000001355.
Engel LS, Chow WH, Vaughan TL, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst. 2003;95(18):1404–13. https://doi.org/10.1093/jnci/djg047.
Shield KD, Marant Micallef C, Hill C, et al. New cancer cases in France in 2015 attributable to different levels of alcohol consumption. Addiction. 2018;113(2):247–56. https://doi.org/10.1111/add.14009.
Brown KF, Rumgay H, Dunlop C, et al. The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015. Br J Cancer. 2018;118(8):1130–41. https://doi.org/10.1038/s41416-018-0029-6.
Wu Y, Li Y, Giovannucci E. Potential impact of time trend of lifestyle risk factors on burden of major gastrointestinal cancers in China. Gastroenterology. 2021;161(6):1830-41.e8. https://doi.org/10.1053/j.gastro.2021.08.006.
Sampson JN, Wheeler WA, Yeager M, et al. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types. J Natl Cancer Inst. 2015;107(12):djv279. https://doi.org/10.1093/jnci/djv279.
Tran GD, Sun XD, Abnet CC, et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer. 2005;113(3):456–63. https://doi.org/10.1002/ijc.20616.
Gao Y, Hu N, Han X, et al. Family history of cancer and risk for esophageal and gastric cancer in Shanxi China. BMC Cancer. 2009;9:269. https://doi.org/10.1186/1471-2407-9-269.
Akbari MR, Malekzadeh R, Nasrollahzadeh D, et al. Familial risks of esophageal cancer among the Turkmen population of the Caspian littoral of Iran. Int J Cancer. 2006;119(5):1047–51. https://doi.org/10.1002/ijc.21906.
Li XY, Su M, Huang HH, et al. mtDNA evidence: genetic background associated with related populations at high risk for esophageal cancer between Chaoshan and Taihang Mountain areas in China. Genomics. 2007;90(4):474–81. https://doi.org/10.1016/j.ygeno.2007.06.006.
Blaydon DC, Etheridge SL, Risk JM, et al. RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome. Am J Hum Genet. 2012;90(2):340–6. https://doi.org/10.1016/j.ajhg.2011.12.008.
Brooks PJ, Enoch MA, Goldman D, et al. The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption. PLoS Med. 2009;6(3):e50. https://doi.org/10.1371/journal.pmed.1000050.
Baan R, Straif K, Grosse Y, et al. Carcinogenicity of alcoholic beverages. Lancet Oncol. 2007;8(4):292–3. https://doi.org/10.1016/s1470-2045(07)70099-2.
Yokoyama A, Kumagai Y, Yokoyama T, et al. Health risk appraisal models for mass screening for esophageal and pharyngeal cancer: an endoscopic follow-up study of cancer-free Japanese men. Cancer Epidemiol Biomarkers Prev. 2009;18(2):651–5. https://doi.org/10.1158/1055-9965.Epi-08-0758.
World Cancer Research Fund/American Institute for Cancer Research. Diet, Nutrition, Physical Activity and Cancer: a Global Perspective. Continuous Update Project Expert Report 2018.
Li WQ, Park Y, Wu JW, et al. Index-based dietary patterns and risk of esophageal and gastric cancer in a large cohort study. Clin Gastroenterol Hepatol. 2013;11(9):1130-36.e2. https://doi.org/10.1016/j.cgh.2013.03.023.
Cheng KK, Day NE, Duffy SW, et al. Pickled vegetables in the aetiology of oesophageal cancer in Hong Kong Chinese. Lancet. 1992;339(8805):1314–8. https://doi.org/10.1016/0140-6736(92)91960-g.
Yang CS. Research on esophageal cancer in China: a review. Cancer Res. 1980;40(8 Pt 1):2633–44.
Vingeliene S, Chan DSM, Vieira AR, et al. An update of the WCRF/AICR systematic literature review and meta-analysis on dietary and anthropometric factors and esophageal cancer risk. Ann Oncol. 2017;28(10):2409–19. https://doi.org/10.1093/annonc/mdx338.
Zhao W, Liu L, Xu S. Intakes of citrus fruit and risk of esophageal cancer: a meta-analysis. Medicine (Baltimore). 2018;97(13):e0018. https://doi.org/10.1097/md.0000000000010018.
Liu J, Wang J, Leng Y, et al. Intake of fruit and vegetables and risk of esophageal squamous cell carcinoma: a meta-analysis of observational studies. Int J Cancer. 2013;133(2):473–85. https://doi.org/10.1002/ijc.28024.
Qiao YL, Dawsey SM, Kamangar F, et al. Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian general population nutrition intervention trial. J Natl Cancer Inst. 2009;101(7):507–18. https://doi.org/10.1093/jnci/djp037.
Zhao Z, Wang F, Chen D, et al. Red and processed meat consumption and esophageal cancer risk: a systematic review and meta-analysis. Clin Transl Oncol. 2020;22(4):532–45. https://doi.org/10.1007/s12094-019-02157-0.
Choi Y, Song S, Song Y, et al. Consumption of red and processed meat and esophageal cancer risk: meta-analysis. World J Gastroenterol. 2013;19(7):1020–9. https://doi.org/10.3748/wjg.v19.i7.1020.
Andrici J, Eslick GD. Maté consumption and the risk of esophageal squamous cell carcinoma: a meta-analysis. Dis Esophagus. 2013;26(8):807–16. https://doi.org/10.1111/j.1442-2050.2012.01393.x.
Lubin JH, De Stefani E, Abnet CC, et al. Maté drinking and esophageal squamous cell carcinoma in South America: pooled results from two large multicenter case-control studies. Cancer Epidemiol Biomarkers Prev. 2014;23(1):107–16. https://doi.org/10.1158/1055-9965.Epi-13-0796.
Ke L. Mortality and incidence trends from esophagus cancer in selected geographic areas of China circa 1970–90. Int J Cancer. 2002;102(3):271–4. https://doi.org/10.1002/ijc.10706.
He Y-T, Hou J, Chen Z-F, et al. Trends in incidence of esophageal and gastric cardia cancer in high-risk areas in China. Eur J Cancer Prev. 2008;17(2).
Andrici J, Eslick GD. Hot food and beverage consumption and the risk of esophageal cancer: a meta-analysis. Am J Prev Med. 2015;49(6):952–60. https://doi.org/10.1016/j.amepre.2015.07.023.
Wu M, Liu AM, Kampman E, et al. Green tea drinking, high tea temperature and esophageal cancer in high- and low-risk areas of Jiangsu Province, China: a population-based case-control study. Int J Cancer. 2009;124(8):1907–13. https://doi.org/10.1002/ijc.24142.
He D, Zhang DK, Lam KY, et al. Prevalence of HPV infection in esophageal squamous cell carcinoma in Chinese patients and its relationship to the p53 gene mutation. Int J Cancer. 1997;72(6):959–64. https://doi.org/10.1002/(sici)1097-0215(19970917)72:6%3c959::aid-ijc7%3e3.0.co;2-o.
Petrick JL, Wyss AB, Butler AM, et al. Prevalence of human papillomavirus among oesophageal squamous cell carcinoma cases: systematic review and meta-analysis. Br J Cancer. 2014;110(9):2369–77. https://doi.org/10.1038/bjc.2014.96.
Koshiol J, Wei WQ, Kreimer AR, et al. No role for human papillomavirus in esophageal squamous cell carcinoma in China. Int J Cancer. 2010;127(1):93–100. https://doi.org/10.1002/ijc.25023.
Sitas F, Egger S, Urban MI, et al. InterSCOPE study: Associations between esophageal squamous cell carcinoma and human papillomavirus serological markers. J Natl Cancer Inst. 2012;104(2):147–58. https://doi.org/10.1093/jnci/djr499.
Halec G, Schmitt M, Egger S, et al. Mucosal alpha-papillomaviruses are not associated with esophageal squamous cell carcinomas: Lack of mechanistic evidence from South Africa, China and Iran and from a world-wide meta-analysis. Int J Cancer. 2016;139(1):85–98. https://doi.org/10.1002/ijc.29911.
Braakhuis BJM, Tabor MP, Kummer JA, et al. A genetic explanation of slaughter’s concept of field cancerization. Can Res. 2003;63(8):1727.
Mohan M, Jagannathan N. Oral field cancerization: an update on current concepts. Oncol Rev. 2014;8(1):244. https://doi.org/10.4081/oncol.2014.244.
Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 1953;6(5):963–8. https://doi.org/10.1002/1097-0142(195309)6:5%3c963::aid-cncr2820060515%3e3.0.co;2-q.
Poon RT, Law SY, Chu KM, et al. Multiple primary cancers in esophageal squamous cell carcinoma: incidence and implications. Ann Thorac Surg. 1998;65(6):1529–34. https://doi.org/10.1016/s0003-4975(98)00177-5.
Shaha AR, Hoover EL, Mitrani M, et al. Synchronicity, multicentricity, and metachronicity of head and neck cancer. Head Neck Surg. 1988;10(4):225–8. https://doi.org/10.1002/j.1930-2398.1988.tb00003.x.
Ho SY, Tsang RKY. Value of oesophagoscopy and bronchoscopy in diagnosis of synchronous malignancies in patients with head and neck squamous cell carcinomas. BMC Cancer. 2020;20(1):1172. https://doi.org/10.1186/s12885-020-07681-9.
Ribeiro U, Jr, Posner MC, Safatle-Ribeiro AV, et al. Risk factors for squamous cell carcinoma of the oesophagus. Br J Surg. 1996;83(9):1174–85.
Chen X, Yuan Z, Lu M, et al. Poor oral health is associated with an increased risk of esophageal squamous cell carcinoma—a population-based case-control study in China. Int J Cancer. 2017;140(3):626–35. https://doi.org/10.1002/ijc.30484.
Guha N, Boffetta P, Wünsch Filho V, et al. Oral health and risk of squamous cell carcinoma of the head and neck and esophagus: results of two multicentric case-control studies. Am J Epidemiol. 2007;166(10):1159–73. https://doi.org/10.1093/aje/kwm193.
Conway D. Oral health, mouthwashes and cancer–what is the story? Evid Based Dent. 2009;10(1):6–7. https://doi.org/10.1038/sj.ebd.6400624.
Li H, Sun D, Cao M, et al. Risk prediction models for esophageal cancer: A systematic review and critical appraisal. Cancer Med. 2021;10(20):7265–76. https://doi.org/10.1002/cam4.4226.
Ishihara R. Endoscopic Diagnosis and Treatment of Superficial Esophageal Squamous Cell Cancer: Present Status and Future Perspectives. Curr Oncol. 2022;29(2):534–43. https://doi.org/10.3390/curroncol29020048.
Morita FH, Bernardo WM, Ide E, et al. Narrow band imaging versus lugol chromoendoscopy to diagnose squamous cell carcinoma of the esophagus: a systematic review and meta-analysis. BMC Cancer. 2017;17(1):54. https://doi.org/10.1186/s12885-016-3011-9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Wong, C., Law, S. (2023). Esophageal Squamous Cell Cancer: Pathogenesis and Epidemiology. In: Schlottmann, F., Ferri, L., Molena, D., Patti, M.G. (eds) Esophageal Cancer. Springer, Cham. https://doi.org/10.1007/978-3-031-39086-9_2
Download citation
DOI: https://doi.org/10.1007/978-3-031-39086-9_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-39085-2
Online ISBN: 978-3-031-39086-9
eBook Packages: MedicineMedicine (R0)